Display search results for ** instead (2 products)

2 Item(s)

18 Mar 2016  |  North America

Vital Signs - Drug Development Focus on Genetically Modified Swine

Modified Swine Hold out Promise of Improving Pre-Clinical Efficacy, Lowering Multi-billion Dollar Drug and Device Development Costs

The US pharmaceutical industry spends approximately $100 billion annually to develop new pharmaceutical drugs and medical devices. Today, a new drug takes approximately 15 years and over $1 billion to bring to market. Product development costs could be greatly reduced by using animal models that more closely resemble humans in their disease states ...

USD 450.00

USD 337.50 save 25 %

18 Mar 2016  |  North America

Vital Signs - Stem Cell Therapy in Ischemic Stroke Recovery

Additional Clinical Trials Critical to Building on Early Promise

As indicated by the World Health Organization, stroke is the second-leading cause of death for people over the age of 60 and is the fifth-leading cause of death for those between the ages of 15 and 59. The incidence of stroke is expected to increase by 25% over the next 20 years. Over 40% of ischemic stroke victims have permanent symptoms and only ...

USD 450.00

USD 337.50 save 25 %

2 Item(s)